DE1620189B1 - 4- (2'-Carbo-alpha-glyceryloxy-phenylamino) -chloroquinoline-acetonide and a process for their preparation - Google Patents
4- (2'-Carbo-alpha-glyceryloxy-phenylamino) -chloroquinoline-acetonide and a process for their preparationInfo
- Publication number
- DE1620189B1 DE1620189B1 DE19661620189D DE1620189DA DE1620189B1 DE 1620189 B1 DE1620189 B1 DE 1620189B1 DE 19661620189 D DE19661620189 D DE 19661620189D DE 1620189D A DE1620189D A DE 1620189DA DE 1620189 B1 DE1620189 B1 DE 1620189B1
- Authority
- DE
- Germany
- Prior art keywords
- chloroquinoline
- phenylamino
- carbo
- acetonide
- glyceryloxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
Description
Die Erfindung betrifft neue 4-(2'-Carbo-a-glyceryloxy-phenylarnino)-chlorchinolin-acetonide der allgemeinen FormelThe invention relates to new 4- (2'-carbo-a-glyceryloxy-phenylarnino) -chloroquinoline-acetonide of the general formula
NHNH
COO — CH2 — CH — CH2 COO - CH 2 - CH - CH 2
in der ein SubstituentX ein Chloratom und der andere ein Wasserstoffatom bedeutet, und ein Verfahren zu ihrer Herstellung.in which a substituent X is a chlorine atom and the others represent a hydrogen atom and a method for their production.
Diese neuen Chinolinderivate besitzen aatiinflammatorische Aktivität und eine bemerkenswerte analgetische Aktivität. Sie wurden bezüglich ihrer antiinflammatorischen Aktivität und ihrer Toxizität mit dem bekannten 4-(2/-Carbo-a-glyceryloxy-phenylamino)-7-chlorchinolin verglichen.These new quinoline derivatives have anti-inflammatory activity and remarkable analgesic activity. In terms of their anti-inflammatory activity and toxicity, they were compared with the well-known 4- (2 / -Carbo-a-glyceryloxy-phenylamino) -7-chloroquinoline.
Antiinflammatorische AktivitätAnti-inflammatory activity
Die angewandte Arbeitsweise ist in der französischen Patentschrift 2413 M beschrieben und besteht darin, daß man durch Injektion von 500 γ Naphthoylheparamin unter Plantaraponeurose der Hinterpfoten von Ratten Entzündungsödeme hervorruft. Die zu untersuchenden Produkte wurde 1 Stunde vor der Injektion auf buccalem Weg verabreicht. Es wurde die ED50 der zu untersuchenden Substanzen bestimmt, d. h. die Dosis, die eine 50%ige Verminderung der Udeme bewirkt.The method used is described in French patent specification 2413 M and consists in causing inflammatory edema by injecting 500 γ naphthoylheparamine under plantar fascia in the hind paws of rats. The products to be tested were administered buccally 1 hour before the injection. The ED 50 of the substances to be examined was determined, ie the dose which causes a 50% reduction in udema.
Folgende Ergebnisse wurden erhalten:The following results were obtained:
7-Chlorderivat: ED50 = 33 mg/kg,
8-Chlorderivat: ED50 ~ 55 mg/kg,7-chlorine derivative: ED 50 = 33 mg / kg,
8-chlorine derivative: ED 50 ~ 55 mg / kg,
4-(2'-Carbo-a-glyceryloxy-phenylamino)-7-chlorchinolin: ED50 = 60 mg/kg.4- (2'-Carbo-a-glyceryloxy-phenylamino) -7-chloroquinoline: ED 50 = 60 mg / kg.
NH-NH-
COORCOOR
IIII
4545
Akute Toxizität bei der Maus (auf buccalem Weg)Acute toxicity in the mouse (buccal route)
7-Chlorderivat: DLs0 = 3 g/kg,
8-Chlorderivat: DL50 = 3,5 g/kg,7-chlorine derivative: DLs 0 = 3 g / kg,
8-chlorine derivative: DL 50 = 3.5 g / kg,
4-(2'-Carbo-a-glyceryloxy-phenylamino)-7-chlorchinolin: DL50 == wenig oberhalb 2 g/kg.4- (2'-Carbo-a-glyceryloxy-phenylamino) -7-chloroquinoline: DL 50 == a little above 2 g / kg.
Die neuen Acetonide werden dadurch hergestellt, daß man in an sich bekannter Weise ein 4-(2'-CaIbalkoxy-phenylamino^chlorchinolin der allgemeinen FormelThe new acetonides are prepared by using a 4- (2'-CaIbalkoxy-phenylamino ^ chloroquinoline in a manner known per se the general formula
5555
in der R einen niederen Alkylrest bedeutet, in Gegenwart eines Alkalimetalls oder eines Amids eines Alkalimetalls mit Glycerinacetonid umsetztin which R is a lower alkyl radical, in the presence of an alkali metal or an amide one Reacts alkali metal with glycerol acetonide
Die folgenden Beispiele erläutern die Erfindung.The following examples illustrate the invention.
4-(2'-Carbo-a-glyceryloxy-phenylamino)-8-cMorchinolin-acetonid 4- (2'-Carbo-a-glyceryloxy-phenylamino) -8-c-Morquinoline-acetonide
Man gibt 43 ecm Glycerinacetonid zu 30 ecm wasserfreiem Toluol, erhitzt unter Stickstoffatmosphäre bei einer Temperatur von 120 bis 125° C, destilliert das Azeotrop Wasser—Toluol ab und zieht schließlich das Toluol im Vakuum ab.43 ecm of glycerol acetonide are added at 30 ecm anhydrous toluene, heated under a nitrogen atmosphere at a temperature of 120 to 125 ° C, The water-toluene azeotrope distills off and draws finally the toluene in vacuo.
Nach dem Abkühlen auf eine Temperatur von 70° C werden 130 mg Natriumamid eingeführt, und man erhitzt IV2 Stunden auf etwa 900C,After cooling to a temperature of 70 ° C 130 mg of sodium amide are introduced, and the mixture is heated IV 2 hours to about 90 0 C,
Darauf wird die Temperatur auf 6O0C gebracht, dann werden 10,4 g 4-(2'-Carbomethoxy-phenylamino)-8-chlorchinoUn eingeführt, und es wird im : Vakuum 5 Stunden auf etwa 80° C erhitzt.Thereafter, the temperature is brought to 6O 0 C, then 10.4 g of 4- (2'-carbomethoxy-phenylamino) -8-chlorchinoUn be introduced, and it is in the: heated for 5 hours at about 80 ° C vacuum.
Es wird abgekühlt, die Lösung wird in erne Mischung Wasser—Methylenchlorid (10:1) gegossen, es wird gerührt und dekantiert.It is cooled, the solution is poured into an internal mixture of water and methylene chloride (10: 1) stirred and decanted.
Die wäßrige Phase wird mit Methylenchlorid extrahiert, die vereinigten Methylenchloridauszüge werden mit Wasser gewaschen, getrocknet und bis zur Trockne destilliert.The aqueous phase is extracted with methylene chloride, the combined methylene chloride extracts are washed with water, dried and distilled to dryness.
Der Rückstand wird mit Petroläther verrieben, abfiltriert und getrocknet. So werden 12,5 g des 4 - (2' - Carbo - α - glyceryloxy - phenylamino) - 8 - chlorchinolin-acetonids erhalten, das nach dem Umkristallisieren aus Äthanol bei 115° C schmilzt.The residue is triturated with petroleum ether, filtered off and dried. So 12.5 g of the 4 - (2 '- Carbo - α - glyceryloxy - phenylamino) - 8 - chloroquinoline acetonides obtained, which melts at 115 ° C after recrystallization from ethanol.
Das Produkt ist in Wasser und Äther unlöslich, es ist in Aceton, Benzol, Chloroform und in der Hitze in Äthanol und Isopropyläther löslich.The product is insoluble in water and ether; it is in acetone, benzene, chloroform and in the heat soluble in ethanol and isopropyl ether.
Analyse: C22H2IO4N2Cl = 412,86.Analysis: C 22 H 2 IO 4 N 2 Cl = 412.86.
Berechnet ... C63,99, H5,13, N6,78, Cl8,59%; gefunden.... C 64,1, H 5,1, N 7,1, Cl 8,6%,Calculated ... C63.99, H5.13, N6.78, Cl8.59%; found .... C 64.1, H 5.1, N 7.1, Cl 8.6%,
Das als Ausgangsstoff benötigte 4-(2'-Carbomethoxy-phenylanrino)-8-chlorchinolin wird auf folgende Weise hergestellt: 15 g 4,8-Dichlorchinolin, hergestellt nach D. S. T a r b e 11 (Journ, Am. Chem. Soc., 68, S. 1277 [1946]), werden in 75 ecm 2n-Chiorwasserstoffsäure eingeführt, 11,5 g Anthranilsäuremethylester werden dann zugefügt. Das Ganze wird unter Rühren 3 Stunden unter Rückfluß erhitzt.The 4- (2'-carbomethoxyphenylanrino) -8-chloroquinoline required as starting material is prepared in the following way: 15 g of 4,8-dichloroquinoline, prepared according to D. S. Tarbe 11 (Journ, Am. Chem. Soc., 68, p. 1277 [1946]), in 75 ecm 2N hydrochloric acid introduced, 11.5 g of anthranilic acid methyl ester are then added. The whole will heated under reflux with stirring for 3 hours.
Sodann wird während 1 Stunde auf Eisbadtemperatur gekühlt und das abgeschiedene Chlorhydrat des 4 - (2' - Carbomethoxy - phenylamino) - 8 - chlorchinolins abgesaugt und mit Wasser gewaschen.It is then cooled to ice bath temperature for 1 hour and the precipitated chlorohydrate des 4 - (2 '- Carbomethoxyphenylamino) - 8 - chloroquinolines filtered off with suction and washed with water.
Um die freie Base zu erhalten, wird das Chlorhydrat in 200 ecm Äthanol gelöst, 50 ecm konzentrierter Ammoniak werden dann bis zur deutlich alkalischen Reaktion zugefügt, und das Ganze wird auf Eisbadtemperatur gekühlt. Der gebildete Niederschlag wird abgesaugt, mit Äther gewaschen und getrocknet. NachTo obtain the free base, the hydrochloride is dissolved in 200 ecm of ethanol, 50 ecm more concentrated Ammonia are then added until the reaction is clearly alkaline, and the whole thing is brought to ice bath temperature chilled. The precipitate formed is filtered off with suction, washed with ether and dried. To
dem Umkristallisieren aus Äthanol werden 13 g 4 - (2' - Carbomethoxy - phenylamino) - 8 - chlorchinolin vom Schmelzpunkt 183 bis 184° C erhalten.recrystallization from ethanol gives 13 g of 4 - (2 '- carbomethoxy - phenylamino) - 8 - chloroquinoline obtained from melting point 183 to 184 ° C.
4-(2'-Carbo-a-gryceryloxy-phenylamino)-7-chlorchinolin-acetonid 4- (2'-Carbo-a-gryceryloxy-phenylamino) -7-chloroquinoline-acetonide
IOIO
Zu 1000 ecm wasserfreiem Glycerinacetonid, das auf 70 bis 75° C erhitzt wurde, werden unter Rühren und unter Spülen mit Stickstoff 5 g Nätriumamid zugefügt, und es wird IV2 Stunden auf etwa 90 bis 95° C erhitzt. Die Lösung wird dann auf etwa 60° C gekühlt, dann werden langsam unter Rühren 500 g 4 - (2' - Carbomethoxy - phenylamino) - 7 - chlorchinolin eingeführt, das nach.dem in der deutschen Patentschrift 1 205 100 beschriebenen Verfahren hergestellt wurde.To 1000 ecm of anhydrous glycerol acetonide which has been heated to 70 to 75 ° C., 5 g of sodium amide are added with stirring and while flushing with nitrogen, and IV is heated to about 90 to 95 ° C. for 2 hours. The solution is then cooled to about 60 ° C., 500 g of 4 - (2 '- carbomethoxyphenylamino) - 7 - chloroquinoline, which was prepared according to the process described in German patent 1 205 100, are then slowly introduced with stirring.
Dann wird die Reaktionsmischung fortschreitend bis zu einer Temperatur von 80° C erhitzt und 5 Stunden auf dieser Temperatur gehalten.Then the reaction mixture is gradually heated up to a temperature of 80 ° C and 5 hours kept at this temperature.
Die Reaktionsmischung wird dann auf Raumtemperatur gekühlt und in eine Mischung von Methylenchlorid und Wasser (1:14) gegossen. Es wird 15 Minuten gerührt; dann wird die organische Phase dekantiert.The reaction mixture is then cooled to room temperature and poured into a mixture of Poured methylene chloride and water (1:14). It is stirred for 15 minutes; then the organic Phase decanted.
Nach erneuter Extraktion der wäßrigen Phase mit Methylenchlorid werden die organischen Phasen vereinigt, filtriert, mit Wasser gewaschen und zur Trockne destilliert.After renewed extraction of the aqueous phase with methylene chloride, the organic phases become combined, filtered, washed with water and distilled to dryness.
Der Rückstand wird mit Petroläther verrieben, abfiltriert und getrocknet. Das so erhaltene 4-(2'-Carbo-a-glyceryloxyphenylamino)-7-chlorchinolin-aceto- nid schmilzt nach dem Umkristallisieren aus Äthanol bei 108°C; Ausbeute 615 g; 94% der Theorie,The residue is triturated with petroleum ether, filtered off and dried. The 4- (2'-Carbo-a-glyceryloxyphenylamino) -7-chloroquinoline-aceto- nid melts after recrystallization from ethanol at 108 ° C; Yield 615 g; 94% of theory,
Claims (4)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR876199A FR1369967A (en) | 1961-10-17 | 1961-10-17 | New quinoline derivatives and method of preparation |
FR899417A FR90802E (en) | 1961-10-17 | 1962-06-01 | New quinoline derivatives and method of preparation |
FR907282A FR1421229A (en) | 1962-08-20 | 1962-08-20 | New quinoline derivative and method of preparation |
FR11769A FR92111E (en) | 1961-10-17 | 1965-04-02 | New quinoline derivatives and method of preparation |
FR23310A FR4775M (en) | 1961-10-17 | 1965-07-02 | |
FR28308A FR90364E (en) | 1962-08-20 | 1965-08-13 | New quinoline derivative and method of preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
DE1620189B1 true DE1620189B1 (en) | 1970-10-01 |
Family
ID=27545985
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19661620189D Pending DE1620189B1 (en) | 1961-10-17 | 1966-03-31 | 4- (2'-Carbo-alpha-glyceryloxy-phenylamino) -chloroquinoline-acetonide and a process for their preparation |
Country Status (9)
Country | Link |
---|---|
US (1) | US3502682A (en) |
BE (1) | BE678550A (en) |
CH (1) | CH470412A (en) |
DE (1) | DE1620189B1 (en) |
DK (1) | DK111819B (en) |
GB (1) | GB1070309A (en) |
IL (1) | IL25233A (en) |
LU (1) | LU50804A1 (en) |
NL (1) | NL6603870A (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR6935M (en) * | 1967-12-29 | 1969-05-05 | ||
US3679687A (en) * | 1970-09-11 | 1972-07-25 | Ciba Geigy Corp | Derivatives of 4-{8 2-(carbocycloalkoxymethyl) phenylimino{9 -1,4-dihydroquinolines |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3132145A (en) * | 1964-05-05 | Pheny | ||
US3232944A (en) * | 1966-02-01 | Monoglycerides 0f (carbgxy pl-ienyl amtno) chlgroqukngltnes | ||
US2769803A (en) * | 1952-04-17 | 1956-11-06 | Bayer Ag | Copolymers of vinyl chloride and 1.1-dichloro-ethene |
CA731646A (en) * | 1962-05-08 | 1966-04-05 | Roussel-Uclaf | 4-(2'(.beta.-MORPHOLYLETHOXYCARBONYL) PHENYLAMINE) 7-CHLORO QUINOLEINE ET SES SELS, AINSI QUE LEUR PROCEDE DE PREPARATION |
-
1966
- 1966-02-22 IL IL25233A patent/IL25233A/en unknown
- 1966-03-24 NL NL6603870A patent/NL6603870A/xx unknown
- 1966-03-28 DK DK158266AA patent/DK111819B/en unknown
- 1966-03-28 BE BE678550D patent/BE678550A/xx not_active IP Right Cessation
- 1966-03-31 DE DE19661620189D patent/DE1620189B1/en active Pending
- 1966-03-31 LU LU50804A patent/LU50804A1/xx unknown
- 1966-03-31 GB GB14382/66A patent/GB1070309A/en not_active Expired
- 1966-03-31 CH CH464166A patent/CH470412A/en not_active IP Right Cessation
-
1969
- 1969-05-15 US US827103A patent/US3502682A/en not_active Expired - Lifetime
Non-Patent Citations (1)
Title |
---|
None * |
Also Published As
Publication number | Publication date |
---|---|
IL25233A (en) | 1969-11-12 |
US3502682A (en) | 1970-03-24 |
CH470412A (en) | 1969-03-31 |
NL6603870A (en) | 1966-10-03 |
LU50804A1 (en) | 1966-07-29 |
BE678550A (en) | 1966-09-28 |
DK111819B (en) | 1968-10-14 |
GB1070309A (en) | 1967-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH472407A (en) | Process for the preparation of new 2-benzyl-1,3,4,9b-tetrahydro-2H-indeno (1,2-c) pyridine derivatives | |
DE1518452B2 (en) | 4-SUBSTITUTED 2-BENZHYDRYL-2BUTANOL DERIVATIVES AND PROCESS FOR THEIR PRODUCTION | |
DE1620189B1 (en) | 4- (2'-Carbo-alpha-glyceryloxy-phenylamino) -chloroquinoline-acetonide and a process for their preparation | |
DE1620189C (en) | 4 (2 Carbo alpha glyceryloxy phenyl amino) chloroquinoline acetomde and a process for their preparation | |
DE1593315C (en) | ||
DE1135921B (en) | Process for the preparation of heterocyclically substituted morphinans and their salts | |
DE1091120B (en) | Process for the preparation of substituted anthranilic acid amides | |
DE1287582B (en) | Process for the preparation of disubstituted isoxazole compounds and their non-toxic salts | |
DE2029991C3 (en) | 2-Hydroxy-5-aminobenzamides, processes for their preparation and pharmaceuticals containing these compounds | |
DE1593315B1 (en) | 9-isopropylidene-9,10-dihydroanthracene-10-carboxylic acid-ß-diaethylamino-ethyl ester, their salts and process for their preparation | |
DE2021747A1 (en) | Process for the preparation of new heterocyclic compounds | |
DE2221123C2 (en) | Reserpic acid derivatives, processes for their preparation and pharmaceuticals | |
DE957842C (en) | Process for the preparation of new octahydropyridopyrimidine compounds | |
DE936446C (en) | Process for the preparation of new amides of pyridine-3, 5-dicarboxylic acid | |
DE1925607C (en) | Trifluoromethyl quinolines | |
AT216152B (en) | Process for the preparation of diesters of deserpidic acid and its salts | |
AT258909B (en) | Process for the preparation of the new 4- (2'-Carbo-α-glyceryloxyphenylamino) -8-chloroquinoline and its salts | |
DE1118197B (en) | Process for the production of 6-azasterines | |
DE1119263B (en) | Process for the production of new sulfonyl urethanes | |
DE2523208C3 (en) | Thienylacetic acid esters, a process for their preparation and pharmaceuticals | |
DE901415C (en) | Process for the preparation of í¸-androstadienol- (17) -one- (3) or its functional derivatives of the hydroxyl group | |
DE1595911C (en) | IH 2,3 Benzoxazin 4 (3H) one and processes for their production | |
DE1445665C (en) | Derivatives of 2 (2 Morpholinoathylmer capto) pyridine compounds | |
DE1235922B (en) | Process for the preparation of new N-substituted 4-phenyl-piperidine-4-carbon-acidic ethyl ester compounds | |
DE1695381B2 (en) | PHTHALAZINO SQUARE CLAMP ON 2.3-ANGLE BRACKET FOR PHTHALAZINE AND A METHOD FOR MAKING IT |